SCHEMBL31330622

SCHEMBL31330622

Cn1c(C2(C)CC2)nc2c(Br)nc(Cl)cc2c1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31330681 0.83 — —
SCHEMBL31278641 0.77 EGFR (0.40) —
SCHEMBL26988300 0.77 EGFR (0.40) —
SCHEMBL31330633 0.75 PARG (0.38) —
SCHEMBL31330595 0.74 RXFP1 (0.33) —
SCHEMBL31330685 0.74 RXFP1 (0.35) —
SCHEMBL31330832 0.74 KDM4E (0.32) —
SCHEMBL31330668 0.74 EGFR (0.35) —
SCHEMBL31278989 0.73 RXFP1 (0.30) —
SCHEMBL31279024 0.73 CYP1A2 (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720061-A1 TREM2 AGONISTS F. Hoffmann-La Roche AG (CH) 2026-04-08 — — EP disclosed
WO-2024246018-A1 TREM2 AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2024-12-05 — — WO disclosed
Send feedback